Head of Finance, Foghorn Therapeutics
As head of finance, Tess Cameron works with Foghorn’s leadership and external stakeholders to ensure that company resources are aligned with strategy and directed toward Foghorn’s mission.
Prior to joining the company, Tess led financial planning and analysis at Wave Life Sciences, where she was responsible for budgeting, forecasting, and corporate finance. Before joining Wave, she held positions of increasing responsibility at Biogen in multiple areas, ranging from strategic corporate finance to program finance and R&D business planning. In her most recent role at Biogen, Tess was the finance lead for the neurodegeneration therapeutic area and several R&D functions. She started her career at McKinsey & Company, where she advised on corporate transactions as a knowledge specialist in the Corporate Finance Practice.
Tess holds a BA with honors from the University of Toronto, where she graduated with distinction with a double major in economics and peace and conflict studies.